The global triple negative breast cancer diagnostics market size was valued at USD 11,401.2 million in 2021. It is expected to reach USD 21.422.3 million by 2028, registering a CAGR of 10.09% over the forecast period 2022-2028. Glance our 200 slides market research and competitive intelligence resea.